Single-cell analysis of a high-grade serous ovarian cancer cell line reveals transcriptomic changes and cell subpopulations sensitive to epigenetic combination treatment.
Ovarian cancer (OC) is a lethal gynecological malignancy with a five-year survival rate of only 46%. Development of resistance to platinum-based chemotherapy is a common cause of high mortality rates among OC patients. Tumor and transcriptomic heterogeneity are drivers of platinum resistance in OC....
Päätekijät: | Shruthi Sriramkumar, Tara X Metcalfe, Tim Lai, Xingyue Zong, Fang Fang, Heather M O'Hagan, Kenneth P Nephew |
---|---|
Aineistotyyppi: | Artikkeli |
Kieli: | English |
Julkaistu: |
Public Library of Science (PLoS)
2022-01-01
|
Sarja: | PLoS ONE |
Linkit: | https://doi.org/10.1371/journal.pone.0271584 |
Samankaltaisia teoksia
-
Single-cell analysis of a high-grade serous ovarian cancer cell line reveals transcriptomic changes and cell subpopulations sensitive to epigenetic combination treatment
Tekijä: Shruthi Sriramkumar, et al.
Julkaistu: (2022-01-01) -
Platinum-induced mitochondrial OXPHOS contributes to cancer stem cell enrichment in ovarian cancer
Tekijä: Shruthi Sriramkumar, et al.
Julkaistu: (2022-05-01) -
Methylomic Signatures of High Grade Serous Ovarian Cancer
Tekijä: Horacio Cardenas, et al.
Julkaistu: (2021-11-01) -
A cell-of-origin epigenetic tracer reveals clinically distinct subtypes of high-grade serous ovarian cancer
Tekijä: Pietro Lo Riso, et al.
Julkaistu: (2020-10-01) -
A single-cell landscape of high-grade serous ovarian cancer
Julkaistu: (2021)